Chipmakers Bring AI Protein Models to Market
News fromCourierPR · 3 min read
AUSTIN, Texas, Sept. 22, 2026 /CourierPR/ -- American News Group News Commentary - Structure prediction, once the exclusive domain of well-funded research organizations, is now becoming standardized, with chipmakers packaging open-source models as ready-to-deploy inference microservices. The Business Research Company projects the AI protein structure prediction market will grow from about $2.33 billion in 2026 to roughly $6.62 billion by 2030, a compound annual growth rate of approximately 29.8%.
MindWalk Holdings Corp. (NASDAQ: HYFT), a Bio-Native AI company, recently validated AMD Inference Microservices for OpenFold3 running on Vultr Kubernetes Engine and Vultr Cloud GPU, powered by AMD Instinct™ MI325X GPUs. The validation demonstrated that a production-grade prediction environment could be deployed in minutes, with antibody-antigen inference time falling by approximately 5x compared to MindWalk's prior environment. The Company's Chief Executive Officer and President, Dr. Jennifer Bath, noted that the validation results reflect the specific configurations evaluated and are not representative of all workloads.
The model itself is not the core differentiator. MindWalk's platform, which includes proprietary, function-aware representations of biology underpinned by HYFT® Technology, forms the basis for the value proposition. The Company's argument is that the validation demonstrates rather than asserts a model-agnostic posture, as it deployed, ran, and measured a third-party open-source model on third-party infrastructure, inside its own discovery workflows and under its own governance and human review.
Advanced Micro Devices, Inc. (NASDAQ: AMD) has reported significant growth in AI infrastructure demand, with the Data Center segment accounting for 58% of company revenue in the second quarter of 2026. AMD's AI Inference Microservices catalog, built by AMD Silo AI and optimized for AMD Instinct GPUs, is available through the Vultr Marketplace as part of the AMD Enterprise AI Software stack. The microservices are containerized, allowing organizations to deploy a packaged model without assembling the underlying inference environment itself.
NVIDIA Corporation (NASDAQ: NVDA) reported a robust second-quarter fiscal 2027 revenue of $96.2 billion, up 106% from a year ago, with Data Center revenue of $89.0 billion, up 117%. The company returned approximately $26.0 billion to shareholders during the quarter through share repurchases and dividends. Jensen Huang, founder and CEO of NVIDIA, highlighted the thriving open-model ecosystem, noting that models like OpenFold3 have been packaged and deployed through its BioNeMo platform.
CoreWeave, Inc. (NASDAQ: CRWV), which describes itself as The Essential Cloud for AI™, reported a revenue backlog of approximately $104 billion as of June 30, 2026, and added more than $25 billion of net new customer commitments in early Q3. The company expanded active power by nearly 500 MW to reach 1.5 GW and grew total contracted power to approximately 3.7 GW. Among its customers are Isomorphic Labs, the AI drug discovery company, Bentley Systems, Caterpillar, Grammarly, and Sunday Robotics.
Nebius Group N.V. (NASDAQ: NBIS) reported second-quarter 2026 revenue of $582.3 million, up 454% from $105.1 million a year earlier, with adjusted EBITDA of $236.2 million compared to a loss of $21.0 million in the prior-year quarter. Non-current deferred revenue rose to approximately $5.0 billion at June 30, 2026, from $1.3 billion at the end of 2025, according to the company's balance sheet. Nebius runs a dedicated Scientific AI and Healthcare practice among its cloud solutions and held an expanded AI Discovery Awards program in July 2026, recognizing healthcare and life sciences innovators.
The release states these figures. Each one belongs in the article exactly as it appears here: will grow from about $2.33 billion in 2026 to roughly $6.62 billion by 2030, a growth rate of approximately 29.8%. As the model itself becomes easier to obtain, the question for drug discovery shifts to what a company brings to it. Companies mentioned in today's commentary include: MindWalk Holdings Corp. (NASDAQ: HYFT), Advanced Micro Devices, Inc. (NASDAQ: AMD), NVIDIA Corporation (NASDAQ: NVDA), CoreWeave, Inc. (NASDAQ: CRWV), and Nebius Group N.V. (NASDAQ: NBIS).